20Apr
Related Posts
22Sep
Factoring climate change risks into financial valuations
21 Sep 2020 - Clayton Utz Partner Brendan Bateman discusses climate change risks, the legal duties of directors and how to factor such risks into financial valuations.
Read More
11Mar
Rural Funds Group (ASX:RFF) HY21 results summary
11 Mar 2021 - Rural Funds Group Limited (ASX:RFF) General Manager - Investor Relations and Marketing, James Powell, presents on the group's HY21 results.
Read More
29May
The world’s highest-grade ionic clay
29 May 2023 - Dr Andrew Tunks, Executive Chairman of Meteoric Resources (ASX:MEI), provides an update on the company's progress, discussing its transition from gold to rare earths, the advantages of ionic clay over hard rock deposits, and promising early results.
Read More
05Oct
QX Resources (ASX:QXR) developing hard rock lithium assets in WA
05 Oct 2022 - QX Resources Limited (ASX:QXR) Managing Director Stephen Promnitz discusses what brought him to QXR, and the company's assets and development stage.
Read More
10Mar
Immunotherapy and autoimmune diseases: A promising new approach
10 Mar 2025 - Addressing Chronic Conditions with Targeted Treatments
Read More
04Mar
2024 RIU Explorers Conference Q&A with Andrew Penkethman of Ardea Resources
04 Mar 2024 - Andrew Penkethman - Managing Director and CEO - Ardea Resources (ASX:ARL) is advancing its flagship 100%-owned Kalgoorlie Nickel Project (KNP). KNP is the largest Nickel–Cobalt resource in Australia and in the top 10 globally, making it of a scale that is incredibly rare and important in the World’s journey to Net Zero. KNP was awarded Major Project Status by the Australian Federal Government, recognising the national and strategic significance of the KNP to the Australian...
Read More
28Aug
Ingenia Communities Group (ASX:INA) FY19 results & outlook
28 Aug 2019 - Ingenia Communities Group Limited (ASX:INA) CFO, Scott Noble discusses the company's FY19 results, its portfolio and the demand for seniors' accommodation.
Read More
01Aug
BARD1 Life Sciences (ASX:BD1) – detecting cancer earlier to save lives, July 2021
29 Jul 2021 - BARD1 Life Sciences Limited (ASX:BD1) CEO Dr Leearne Hinch introduces the company, discussing its recent capital raising and share purchase plan.
Read More
17Nov
Genetic Signatures (ASX:GSS) – detecting infectious diseases in high-throughput lab workflows
17 Nov 2022 - Genetic Signatures Limited (ASX:GSS) CEO and Director Dr John Melki discusses the company's technology, business model, 2022 highlights and outlook.
Read More
10Feb
Centuria Capital Group (ASX:CNI) 1H21 results & outlook
10 Feb 2021 - Centuria Capital Group Limited (ASX:CNI) Joint CEO, John McBain talks 1H21 results & outlook, transactions and financial highlights.
Read More